Lantern Pharma is a clinical stage oncology company that leverages Artificial Intelligence, Machine Learning, and genomics to develop targeted cancer therapies. Lantern develops therapies using genomic data, computational biology modeling, and Artificial Intelligence techniques to clarify the potential mechanism of action underlying drug-tumor response and to identify the patient groups most likely to respond to a therapy.
Let's Chat!
Today we are able to understand the genomic or biomarker basis of why certain patients respond exquisitely to certain therapies in cancer, while others fail to respond at all. At the same time, we are now able to access the computing power and algorithms required to make sense of the clinical and scientific data that is available to us, and then propose precision-focused trials that provide us with a compressed development timeline.